Publications

5803 Results

Phase II evaluation of recombinant interleukin-2 rIL-2) inmetastatic renal cell carcinoma (RCC):SWOG-8617

Authors
RM Bukowski;P Goodman;ED Crawford;JS Sergi;L Baker;J Neidhart
Journal / Conference
ASCO 8:143(#556)
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8617

Weekly cis-platin (CDDP) based induction for extensive non-smallcell lung cancer (NSCLC) with cis-platin and VP-16 consolidation.

Authors
CS Higano;J Crowley;RB Livingston
Journal / Conference
ASCO 8:227(#882)
Year
1989
Research Committee(s)
Lung
Study Number(s)
SWOG-8625

Randomized phase II trial of recombinant gamma interferonadministered on two schedules in advanced colorectal cancer: ASouthwest Oncology Group trial.

Authors
T Brown;T Fleming;P Goodman;J Macdonald
Journal / Conference
ASCO 8:124(#482)
Year
1989
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8630

Continuous infusion recombinant gamma interferon (CIr-GIFN) forrenal cell carcinoma (RCC).

Authors
J Kuebler;T Brown;P Goodman;D Crawford;C Reitz;W Knight;J Kish
Journal / Conference
ASCO 8:140(#544)
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8707

A phase II trial of amonafide in advanced renal cell carcinoma.

Authors
CS Higano;J Craig;P Goodman;B Blumenstein;J Wettlaufer;ED Crawford
Journal / Conference
ASCO 8:147(#574)
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8716

Phase II trial of amonafide in advanced prostate cancer: ASouthwest Oncology Group study.

Authors
J Craig;E Crawford
Journal / Conference
ASCO 8:147(#573)
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8722

Phase II trial of didemnin B (Did-B) in advanced adenocarcinomaof the kidney.

Authors
S Taylor;B Pistone;RL Stephens;ED Crawford
Journal / Conference
ASCO 8:145(#564)
Year
1989
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8728

Prognostic factors in limited small cell (LSC) lung cancer reconsidered: Southwest Oncology Group (SWOG) studies.

Authors
K Albain;J Crowley;R Livingston
Journal / Conference
ASCO 8:225(#876)
Year
1989
Research Committee(s)
Lung

Significance of HLA-DR and FC receptor expression in acute non-lymphoblastic leukemia (ANLL).

Authors
L Elias;DE Van Epps;JS Hewlitt;FR Appelbaum;DP Head;KJ Kopecky;MR Grever
Journal / Conference
ASCO 8:200(#776)
Year
1989
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8124/25/26

Combine therapy for resectable head and neck cancer: A phase III study.

Authors
DE Schuller;G Laramore;M Al-Sarraf;J Jacobs;TF Pajak
Journal / Conference
Archives of Otolaryngology-Head and Neck Surgery 115:364-368
Year
1989
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)